Trial site
Cancer Hospital of Shandong First Medical University (Shandong Cancer Institute, Shandong Cancer Hospital)
- 12running trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer2 trials
- Lung cancer2 trials
- Metastatic breast cancer2 trials
- Brain metastases1 trial
- Diffuse large B-cell lymphoma1 trial
- Gastric and oesophageal cancer1 trial
- Liver and biliary tract cancer1 trial
- Multiple myeloma1 trial
- Pancreatic cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 35 trials
- Phase 1/23 trials
- Phase 23 trials
- Phase 11 trial
- Status
- Not yet recruiting7 trials
- Active, not recruiting3 trials
- Recruiting2 trials
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2 trials
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.2 trials
- Akeso1 trial
- Eikon Therapeutics1 trial
- Elpiscience (Suzhou) Biopharma, Ltd.1 trial
- and 5 more
Running trials
Recruiting
Not yet recruiting
Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple Myeloma
Recruiting
Not yet recruiting
Recruiting
Recruiting
TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer
Active, not recruiting
Recruiting
A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
Active, not recruiting
Evaluation of TQB3616 Capsules in a Phase II Clinical Trial for Recurrent/Metastatic Breast Cancer
Recruiting
Recruiting
A Study of AK112 in Patients With Advanced Hepatocellular Carcinoma (HCC)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Brain metastases1 recruiting
- Colorectal cancer1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Multiple myeloma1 recruiting
- Pancreatic cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026